Cortisol in the Treatment of Phobias

Not Applicable

Completed

• Conditions: Phobia

• Registration Number: NCT00451750
• Lead Sponsor: University of Zurich

Brief Summary

The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in patients with phobia.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2007-03-21
• Study First Submitted QC: 2007-03-21
• Study First Posted: 2007-03-23
• Study Start: 2007-05
• Primary Completion: 2009-09
• Study Completion: 2009-09
• Status Verified: 2010-01
• Last Update Submitted: 2010-01-11
• Last Update Posted: 2010-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Female and male patients with a specific phobia (fear of heights) according to DSM-IV criteria.

Exclusion Criteria

• Severe acute or chronic somatic diseases
• Psychiatric disorder other than specific phobia
• Topic glucocorticoid therapy (for large skin parts)
• Inhaled glucocorticoids
• Psychotropic medication
• Pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
visual analog scales for fear and acrophobia questionnaires	1 month

Trial Locations

Locations (1)

University of Basel; 🇨🇭 Basel, Switzerland